Luke is joined by dementia specialist Tim England, about a change that is coming in the treatment of dementia. 

There has been much media coverage recently about a new drug treatment for Alzheimer's Disease. Called Lecanemab, which is sold under the brand name Leqembi, this drug was approved for medical use in the United States in January this year and as reported yesterday was fully approved by the American Federal Drug Administration.

With all new treatments really for any illness, some of the reporting is claiming this drug to be a ‘Game changer’ where other reports promote a level of caution. 

Regular guest and dementia educator, Tim England, explains to Luke what he knows.

Luke is joined by dementia specialist Tim England, about a change that is coming in the treatment of dementia. 
There has been much media coverage recently about a new drug treatment for Alzheimer's Disease. Called Lecanemab, which is sold under the brand name Leqembi, this drug was approved for medical use in the United States in January this year and as reported yesterday was fully approved by the American Federal Drug Administration.
With all new treatments really for any illness, some of the reporting is claiming this drug to be a ‘Game changer’ where other reports promote a level of caution. 
Regular guest and dementia educator, Tim England, explains to Luke what he knows.

Australia Overnight with Mike Jeffreys, 12am – 4am weekdays.

Wake Up Australia, 4am - 9:30am weekdays.

Australia Overnight with Mike Jeffreys, 12am – 4am weekdays.
Wake Up Australia, 4am - 9:30am weekdays.

Advertisement